In order to validate the AMG 330-triggered redirection of T-cells towards CD33+ AML-blasts AML-PBMC samples from newly diagnosed patients were used for short-term (three to six days) cell cultures in presence of control BiTE® constructs or AMG 330. Here, CD33 is linked to acute myeloid leukemia.